Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer

By  

CANCER, Vol. 120, Iss. 18, 2014-09 ,pp. : 2876-2882

John Wiley & Sons Inc

Access to resources Recommend Favorite

Some prostate cancers are invisible to magnetic resonance imaging!

By  

BJU INTERNATIONAL, Vol. 118, Iss. 4, 2016-10 ,pp. : 492-493

John Wiley & Sons Inc

Access to resources Recommend Favorite

In‐parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance

By  

BJU INTERNATIONAL, Vol. 118, Iss. 4, 2016-10 ,pp. : 527-534

John Wiley & Sons Inc

Access to resources Recommend Favorite

Imaging in prostate cancer with multiparametric magnetic resonance imaging and gallium positron emission tomography‐computed tomography: ‘the real deal'?

By  

BJU INTERNATIONAL, Vol. 115, Iss. S5, 2015-04 ,pp. : 1-2

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiparametric Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Targeted Biopsy of the Prostate: Preliminary Results of a Prospective Single-Centre Study

By  

Urologia Internationalis, Vol. 94, Iss. 3, 2015-01 ,pp. : 313-318

Karger

Access to resources Recommend Favorite